-+ 0.00%
-+ 0.00%
-+ 0.00%

Ping An Biomedical Plans to Buy Three Tumor-Related Patents for USD 2 Million-2.5 Million

PUBT·10/22/2026 19:30:49
Listen to the news
Ping An Biomedical Plans to Buy Three Tumor-Related Patents for USD 2 Million-2.5 Million
  • Ping An Biomedical signed a letter of intent to acquire three tumor-related medical technology patents from Future Biotechnology Group.
  • The proposed acquisition, valued at US$ 2 million to US$ 2.5 million, would establish a core oncology and biotechnology patent portfolio.
  • Completion remains subject to due diligence and a definitive acquisition agreement.
  • The acquisition alone is not expected to generate material revenue in the near term.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610221530PRIMZONEFULLFEED9851353) on October 22, 2026, and is solely responsible for the information contained therein.